Does CABOTEGRAVIR Cause Product dose omission issue? 1,121 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,121 reports of Product dose omission issue have been filed in association with CABOTEGRAVIR (Apretude). This represents 13.5% of all adverse event reports for CABOTEGRAVIR.
1,121
Reports of Product dose omission issue with CABOTEGRAVIR
13.5%
of all CABOTEGRAVIR reports
0
Deaths
37
Hospitalizations
How Dangerous Is Product dose omission issue From CABOTEGRAVIR?
Of the 1,121 reports, 37 (3.3%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOTEGRAVIR. However, 1,121 reports have been filed with the FAERS database.
What Other Side Effects Does CABOTEGRAVIR Cause?
Off label use (1,049)
Injection site pain (924)
Viral load increased (452)
Pain (399)
Virologic failure (275)
Pathogen resistance (270)
Pyrexia (255)
Product use in unapproved therapeutic environment (234)
Inappropriate schedule of product administration (228)
Product complaint (213)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which CABOTEGRAVIR Alternatives Have Lower Product dose omission issue Risk?
CABOTEGRAVIR vs CABOTEGRAVIR\RILPIVIRINE
CABOTEGRAVIR vs CABOZANTINIB
CABOTEGRAVIR vs CABOZANTINIB S-MALATE
CABOTEGRAVIR vs CAFFEINE
CABOTEGRAVIR vs CALASPARGASE PEGOL